Fig. 28From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluationQuantifying cell count with Image J after tissue treatment with primary antibodies COX-II, TNF-α and NFκB via immunohistochemistry protocols. n = 10, mean + SD, p ≤ 0.05Back to article page